Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)

China flag China · Delayed Price · Currency is CNY
16.93
+0.25 (1.50%)
Apr 28, 2026, 3:00 PM CST
-7.18%
Market Cap 56.58B
Revenue (ttm) 283.58B
Net Income (ttm) 5.72B
Shares Out 3.71B
EPS (ttm) 1.54
PE Ratio 10.99
Forward PE 11.57
Dividend 0.47 (2.82%)
Ex-Dividend Date Jan 5, 2026
Volume 9,085,999
Average Volume 11,151,863
Open 16.70
Previous Close 16.68
Day's Range 16.70 - 16.97
52-Week Range 16.23 - 19.68
Beta 0.30
RSI 47.24
Earnings Date Mar 30, 2026

About SHA:601607

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in... [Read more]

Sector Healthcare
Founded 1994
Employees 49,608
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 601607
Full Company Profile

Financial Performance

In 2025, SHA:601607's revenue was 283.58 billion, an increase of 3.03% compared to the previous year's 275.25 billion. Earnings were 5.72 billion, an increase of 25.74%.

Financial Statements

News

There is no news available yet.